Does Route of Administration for Estrogen Hormone Therapy Impact Risk of Venous Thromboembolism: Estradiol Transdermal System vs. Oral Estrogen-Only Hormone Therapy

被引：0
作者：
Laliberte, Francois [1 ]
Dea, Katherine [1 ]
Duh, Mei Sheng [2 ]
Kahler, Kristijan H. [3 ]
Rolli, Melanie [3 ]
Lefebvre, Patrick [1 ]
机构：
[1] Ltee, Grp Anal, Montreal, PQ, Canada
[2] Anal Grp Inc, Boston, MA USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2010年 / 17卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1224 / 1224
页数：1
相关论文
共 50 条
  • [31] MENOPAUSAL HORMONE THERAPY AND RISK OF INCIDENT HYPERTENSION: IMPACT OF THE ROUTE OF ESTROGEN ADMINISTRATION AND PROGESTOGENS IN THE E3N COHORT
    Madika, Anne-Laure
    Macdonald, Conor-James
    Fournier, Agnes
    Mounier-Vehier, Claire
    Beraud, Guillaume
    Boutron-Ruault, Marie-Christine
    JOURNAL OF HYPERTENSION, 2021, 39 : E403 - E403
  • [32] Venous Thromboembolism and Cardiovascular Disease Complications in Women using Transdermal Versus Oral Menopausal Estrogen Therapy
    Simon, James A.
    Laliberte, Francois
    Duh, Mei Shengh
    Pilon, Dominic
    Kahler, Kristijan H.
    Nyirady, Judtih
    Davis, Pamela J.
    Lefebvre, Patrick
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (12): : 1324 - 1324
  • [33] Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy
    Simon, James A.
    Laliberte, Ois
    Duh, Mei Sheng
    Pilon, Dominic
    Kahler, Kristijan H.
    Nyirady, Judit
    Davis, Pamela J.
    Lefebvre, Patrick
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (06): : 600 - 610
  • [34] A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy
    Douketis, JD
    Ginsberg, JS
    Holbrook, A
    Crowther, M
    Duku, EK
    Burrows, RF
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (14) : 1522 - 1530
  • [35] Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy REPLY
    Iversen, Lisa
    Hannaford, Philip C.
    Fielding, Shona
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (02) : 233 - 233
  • [36] Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen Correction (vol 47, pg 1734, 2016)
    Canonico, M.
    Carcaillon, L.
    Plu-Bureau, G.
    Oger, E.
    Singh-Manoux, A.
    Tubert-Bitter, P.
    Elbaz, A.
    Scarabin, P-Y.
    STROKE, 2016, 47 (07) : e204 - e204
  • [37] Differential effects of oral vs. transdermal estrogen replacement therapy on serum amyloid A in postmenopausal women
    Vongpatanasin, W
    Abbas, AA
    Wang, ZY
    Fadel, PJ
    Arbique, D
    Jialal, I
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 245A - 245A
  • [38] Perioperative Estrogen Hormonal Therapy Does Not Increase Venous Thromboembolism Risk in Facial Feminization Surgery
    Li, Alexander Y.
    Park, Matthew J.
    Fick, Jennifer
    Ousterhout, Douglas K.
    Deschamps-Braly, Jordan C.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 154 (06) : 1309 - 1315
  • [39] Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
    Skeith, Leslie
    Le Gal, Gregoire
    Rodger, Marc A.
    THROMBOSIS RESEARCH, 2021, 202 : 134 - 138
  • [40] Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review
    Wu, O
    Robertson, L
    Langhorne, P
    Twaddle, S
    Lowe, GDO
    Clark, P
    Greaves, M
    Walker, ID
    Brenkel, I
    Regan, L
    Greer, IA
    THROMBOSIS AND HAEMOSTASIS, 2005, 94 (01) : 17 - 25
12345